Recent Advances in Non-viral Gene Delivery

Advances in Genetics

Volumn 53, Issue , 2005, Pages 1-18

  Conwell, Christine C ^a   Huang, Leaf ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; LIPOSOME; POLYETHYLENE DERIVATIVE;

GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; PH; REVIEW;

CATIONS; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; POLYETHYLENES;

EID: 33645873289     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(05)53001-3     Document Type: Review

References (68)

1. Ahn C., Chae S., Bae Y., and Kim S. Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier. J. Controlled Release 97 (2004) 567-574
2. Anderson D., Lynn D., and Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. 42 (2003) 3153-3158
3. Arangoa M., Duzgunes N., and Tros de Ilarduya C. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asiolofetuin-lipoplexes. Gene Thera. 10 (2003) 5-14
4. Asokan A., and Cho M. Exploitation of intracellular pH gradients in the cellular delivery of macromolecules. J. Pharm. Sci. 91 (2002) 903-913
5. Boussif O., Lezoualch F., Zanta M., Mergney M., Scherman D., Demeneix B., and Behr J. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Nat. Acad. Sci. USA 92 (1995) 7297-7301
6. Brownlie A., Uchegbu I., and Schatzlein A. PEI-based vesicle-polymer hybrid gene delivery sustem with improved biocompatibility. Int. J. Pharm. 274 (2004) 41-52
7. Brzoska M., Langer K., Coester C., Loitsch S., Wagner T., and Mallinckrodt C. Incorporation of biodegradable nanoparticles into human airway epothelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem. Biophys. Res. Commun. 318 (2004) 562-570
8. Bureau M., Gehl J., Deleuze V., Mir L., and Scherman D. Importance of association between permeablization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim. Biophys. Acta 1474 (2000) 353-359
9. Bureau M., Naimi S., Torero Ibad R., Seguin J., Georger C., Arnould E., Maton L., Blanche F., Delaere P., and Scherman D. Intramuscular plasmid DNA electrotransfer: Biodistribution and degradation. Biochim. Biophys. Acta 1676 (2004) 138-148
10. Chellat F., Grandjean-Laquerrier A., Le Naour R., Fernandes J., Yahia L., Guenounou M., and Laurent-Maquin D. Metalloproteinase and cytokine production by THP1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 26 (2005) 961-970
11. Chollet P., Favrot M., Hurbin A., and Coll J. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4 (2004) 84-91
12. Dauty E., Remy J., Blessing T., and Behr J. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J. Am. Chem. Soc. 123 (2001) 9227-9234
13. Dauty E., Remy J., Zuber G., and Behr J. Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjugate Chem. 13 (2002) 831-839
14. Dileo J., Banerjee R., Whitmore M., Nayak J.V., Falo L.D., and Huang L. Lipid-protamine-DNA-mediated antigen delivery to antigen presenting cells results in enhanced anti-tumor immune responses. Mol. Ther. 7 (2003) 640-648
15. Dileo J., Miller T., Chesnoy S., and Huang L. Gene transfer to subdermal tissues via a new gene gun design. Hum. Gene Thera. 14 (2003) 79-87
16. Drummond D., Zignani M., and Leroux J. Current status of pH- sensitive liposomes in drug delivery. Prog. Lipid Res. 39 (2000) 409-460
17. Felgner P., Gadek T., Holm M., Roman R., Chan H., Wenz M., Northrop J., Ringold G., and Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Nat. Acad. Sci. USA 84 (1987) 7413-7417
18. Fischer D., Bieber T., Li Y., Elsasser H., and Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine; Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16 (1999) 1273-1279
19. Furgeson D., Chan W., Yockman J., and Kim S. Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjugate Chem. 14 (2003) 840-847
20. Furgeson D., Cohen R., Mahato R., and Kim S. Novel water insoluble lipoparticulates for gene delivery. Pharm. Res. 19 (2002) 382-390
21. Gerasimov O., Boomer J., Qualls M., and Thompson D. Cytosolic drug delivery using pH-and light-sensitive liposomes. Adv. Drug Delivery Rev. 38 (1999) 317-338
22. Guo X., and Szoka F.J. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate. Bioconjugate Chem. 12 (2001) 291-300
23. Guo X., and Szoka F.J. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 36 (2003) 335-341
24. Hong J., Park J., Huh K., Chung H., Kwon I., and Jeong S. PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system. J. Controlled Release 99 (2004) 167-176
25. Huth S., Lausier J., Gersting S., Rudolph C., Plank C., Welsch U., and Rosenecker J. Insights into the mechanisms of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6 (2004) 923-936
26. Kabanov A., Batrakova E., and Alakhov V. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Controlled Release 82 (2002) 189-212
27. Kichler A. Gene transfer with modified polyethylenimines. J. Gene Med. 6 (2004) S3-S10
28. Kircheis R., Wightman L., and Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deli. Rev. 53 (2001) 341-358
29. Koping-Hoggard M., Varum K., Issa M., Danielsen S., Christensen B., Stokke B., and Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Thera. 11 (2004) 1441-1452
30. Kramer M., Stumbe J., Grimm G., Kaufmann B., Kruger U., Weber M., and Haag R. Dendritic polyamines: Simple access to new materials with defined treelike structures for application in non-viral gene delivery. Chembiochem 5 (2004) 1081-1087
31. Kumar M., Behera A., Lockey R., Zhang J., Bhullar G., de la Cruz C., Chen L., Leong K., Huang S., and Mohapatra S. Intranasal gene transfer by chitosan- DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum. Gene Thera. 13 (2002) 1415-1425
32. Kwok K., Park Y., Yang Y., McKenzie D., Liu Y., and Rice K. In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. J. Pharm. Sci. 92 (2003) 1174-1185
33. Lemieux P., Guerin N., Paradis G., Proulx R., Chistyakova L., Kabanov A., and Alakhov V. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Thera. 7 (2000) 986-991
34. Li S., and Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Thera. 4 (1997) 891-900
35. Li S., Rizzo M.A., Bhattacharya S., and Huang L. Characterization of catinoi lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Therapy 5 (1998) 930-937
36. Li Z., and Huang L. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxyl-L-proline). J. Controlled Release 98 (2004) 437-446
37. Lim Y., Han S., Kong H., Lee Y., Park J., Jeong B., and Kim S. Biodegradable polyester, poly[a-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17 (2000) 811-816
38. Lim Y., Kim S., Suh H., and Park J. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxix gene delivery carrier. Bioconjugate Chem. 13 (2002) 952-957
39. Liu F., and Huang L. Noninvasive gene delivery to the liver by mechanical massage. Hepatology 35 (2002) 1314-1319
40. Liu F., and Huang L. A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol. Therapy 5 (2002) 323-328
41. Liu F., Lei J., Vollmer R., and Huang L. Mechanism of liver gene transfer by mechanical massage. Mol. Therapy 9 (2004) 452-457
42. Liu F., Shollenberger L., and Huang L. Non-immunostimulatory non-viral vectors. FASEB 18 (2004) 1779-1781
43. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., and Fernandes J. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Stratagies to improve transfection efficacy. Eur. J. Pharm. Biopharma. 57 (2004) 1-8
44. Maruyama H., Higuchi N., Nishikawa Y., Hirahara H., Iino N., Kameda S., Kawachi H., Yaoita E., Gejyo F., and Miyazaki J. Kidney targeted naked DNA transfer by retrograde renal vein injection in rats. Human Gene Thera. 13 (2002) 455-468
45. Miyata K., Kakizawa Y., Nishiyama M., Harada A., Yamasaki Y., Koyama H., and Katoaka K. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expresion. J. Am. Chem. Soc. 126 (2004) 2355-2361
46. Nyode A., Merlin J., Leroux A., Dolivet G., Erbacher P., Behr J., Berg K., and Guillemin F. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalization of glucosylated PEI-DNA complexes. J. Gene Med. 6 (2004) 884-894
47. Ogris M., Brunner S., Schuller S., Kircheis R., and Wagner E. PEGylated DNA/ transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Thera. 6 (1999) 595-605
48. Putnam D., Zelikin A., Izumrudov V., and Langer R. Polyhistidine-PEG: DNA nanocomposites for gene delivery. Biomaterials 24 (2003) 4425-4433
49. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., Gansbacher B., and Plank C. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Thera. 9 (2002) 102-109
50. Simoes S., Slepushkin V., Pires P., Gaspar R., Pedroso de Lima M., and Duzgunes N. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim. Biophys. Acta 1463 (2004) 459-469
51. Tan Y., Liu F., Li Z., Li S., and Huang L. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol. Thera. 3 (2001) 673-682
52. Thomas J., and Tirrell D. Polymer-induced leakage of cations from dioleoyl phosphatidylcholine and phosphatidylglycerol liposomes. J. Controlled Release 76 (2000) 203-209
53. Thompson D., Gerasimov O., Wheeler J., Rui Y., and Anderson V. Triggerable plasmalogen liposomes: Improvements of system efficiency. Biochim. Biophys. Acta 1279 (1996) 25-34
54. Unger E., Porter T., Culp W., Labell R., Matsunga T., and Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv. Drug Delivery Rev. 56 (2004) 1291-1314
55. Vilfan I., Conwell C., and Hud N. Formation of native-like mammalian sperm cell chromatin with folded bull protamine. J. Biol. Chem. 279 (2004) 20088-20095
56. Wadhwa M., Collard W., Adami R., McKenzie D., and Rice K. Peptide-mediated gene delivery: influence of peptide structure on gene expression. Bioconjugate Chem. 8 (1997) 81-88
57. Walther W., Stein U., Fichtner I., Malcherek L., Lemm M., and Schlag P. Non-viral in vivo gene delivery into tumor using a novel low volume jet-injection technology. Gene Thera. 8 (2001) 173-180
58. Wells D. Gene therapy progress and prospects: electroporation and other physical methods. Gene Thera. 11 (2004) 1363-1369
59. Whitmore M., Li S., Falo Jr. L., and Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumore immune response. Cancer Immunol. Immunothera. 50 (2001) 503-514
60. Xu L., Huang C., Huang W., Tang W., Rait A., Yin Y., Cruz I., Xiang L., Pirollo K., and Chang E. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv- immunoliposomes. Mol. Cancer Thera. 1 (2002) 337-346
61. Yang N., Burkholder J., Roberts B., Martinell B., and McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Nat. Acad. Sci. USA 87 (1990) 9568-9572
62. Yatvin M., Kreutz W., Horwitz B., and Shinitzky M. pH-sensitive liposomes: Possible clinical implications. Science 210 (1980) 1253-1255
63. Yu W., Pirollo K., Rait A., Yu B., Xiang L., Huang W., Zhou Q., Ertem G., and Chang E. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther. 11 (2004) 1-7
64. Zeira E., Manevitch A., Khatchatouriants A., Pappo O., Hyam E., Darash-Yahana M., Tavor E., Honigman A., Lewis A., and Galun E. Femto-second infrared laser- an efficient and safe in vivo gene delivery system for prolonged expression. Mol. Thera. 8 (2003) 342-350
65. Zhang G., Budker V., Williams P., Subbotin V., and Wolff J. Efficient expression of naked DNA delivered intraarterialy to limb muscles of nonhuman primates. Human Gene Thera. 12 (2001) 427-438
66. Zhang G., Gao X., Song Y., Vollmer R., Stolz D., Gasiorowski J., Dean D., and Liu D. Hydroporation as the mechanism of hydrodynamic delivery. Gene Therapy 11 (2004) 675-682
67. Zhang L., Nolan E., Kreitschitz S., and Rabussay D. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim. Biophys. Acta 1572 (2002) 1-9
68. Zuber G., Zammut-Italiano L., Dauty E., and Behr J. Targeted gene delivery to cancer cells: Directed assembly of nanometric DNA particles coated with folic acid. Angew. Chem. 42 (2003) 2666-2699